Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,587 recruiting studies in this area right now.
By phase
- Not applicable9,776
- Phase 24,446
- Phase 12,737
- Phase 1/Phase 21,691
- Phase 31,394
- Phase 2/Phase 3280
- Phase 4263
Top conditions
- Breast Cancer1,226
- Cancer660
- Prostate Cancer651
- Colorectal Cancer494
- Lung Cancer425
- Ovarian Cancer340
- Multiple Myeloma332
- Gastric Cancer298
- Acute Myeloid Leukemia292
- Pancreatic Cancer292
- Hepatocellular Carcinoma283
- Solid Tumor256
- Advanced Solid Tumor255
- Cervical Cancer232
- Head and Neck Cancer226
- Endometrial Cancer206
- Advanced Solid Tumors192
- Bladder Cancer192
Leading sponsors
- M.D. Anderson Cancer Center451
- Fudan University312
- Sun Yat-sen University291
- Memorial Sloan Kettering Cancer Center289
- National Cancer Institute (NCI)287
- Mayo Clinic242
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center148
- AstraZeneca133
- University Health Network, Toronto125
Where studies are running
- California1,428
- Texas638
- Arizona513
- Florida448
- Alabama421
- New York407
- Massachusetts342
- Maryland329
- New Jersey267
- Pennsylvania245
Recruiting studies20,587 total
- NCT06258863Enrolling by invitation
Comparing incision types in breast reconstruction after mastectomy
This study compares different types of surgical cuts (incisions) used during breast reconstruction after mastectomy. It looks at which incision gives the best cosmetic result and causes the fewest problems. Researchers want to find out which technique is best for you.
Wuhan, Hongshan DistrictAges 18 years+ - NCT06189079Recruiting
Arterial embolization for painful bone metastases
This study tests a procedure called arterial embolization, which blocks blood flow to bone tumors, to see if it can reduce pain or prevent fractures. It is for people with bone cancer that has spread from another cancer (metastases).
Bologna, Emilia-RomagnaAges 18 years+ - NCT06320067RecruitingPhase 3
Testing treatments for metastatic hormone-sensitive prostate cancer
This trial tests two newer treatments—targeted radiation (SABR) or a special radioactive drug (Lu-177 PSMA-617)—added to standard hormone therapy for men with prostate cancer that has spread. The goal is to see if these additional treatments help control the cancer better.
BarnsleyAges 18 years+ - NCT06253234RecruitingPhase 1
DC vaccine for recurrent high-grade gliomas
This trial tests a vaccine made from your own immune cells (dendritic cells) to see if it can help control recurrent or progressive high-grade gliomas. It is for people whose brain tumor has returned after standard treatments.
Beijing, Beijing MunicipalityAges 18–75 - NCT06182072RecruitingPhase 1
ProAgio for advanced pancreatic cancer
This trial tests a new drug called ProAgio combined with standard chemotherapy for people with stage IV pancreatic cancer. It aims to see if the combination is safe and effective.
Birmingham, AlabamaAges 18 years+ - NCT06234306Recruiting
Genetic testing for small bowel cancer
This trial studies the genetic makeup of small bowel adenocarcinoma to find better treatments. It involves testing leftover tumor tissue from past biopsies or surgeries.
Aarhus NAges 18 years+ - NCT06225726Recruiting
Bladder tumor stiffness study with ultrasound
This trial uses a special ultrasound technique to measure the stiffness of bladder tumors. It may help doctors understand tumors better before surgery.
ToursAges 18 years+ - NCT06311942RecruitingPhase 4
Comparing triple vs. dual therapy after liver surgery for liver cancer
This trial tests whether adding a third drug to standard two-drug therapy after liver surgery helps prevent liver cancer from returning. It is for people who have a specific blood vessel pattern in their tumor, called VETC, seen on a special stain.
Wuhan, HubeiAges 18–75 - NCT06281405RecruitingPhase 2
CAPOX and immunotherapy with or without radiation for rectal cancer
This trial tests whether adding radiation therapy to a combination of chemotherapy (CAPOX) and an immunotherapy drug (PD-1 antibody) is more effective than the combination alone for people with locally advanced rectal cancer that is MSS (microsatellite stable) or pMMR. It aims to improve outcomes for patients with high-risk features.
ShanghaiAges 18–70 - NCT06280508RecruitingPhase 2
Perioperative chemo plus immunotherapy for bile duct cancer
This trial tests a combination of chemotherapy, immunotherapy (adebrelimab), and a targeted therapy (apatinib) before and after surgery for bile duct cancer that can be removed and has a high risk of coming back. It aims to see if this approach can lower the chance of recurrence.
Guangzhou, China/GuangdongAges 18 years+ - NCT06246071RecruitingPhase 1
TYK-00540 for adults with solid tumors
This trial tests a new drug, TYK-00540, for people with solid tumors that have not responded to or cannot tolerate standard treatments. It also looks at specific types of breast and ovarian cancer.
HefeiAges 18 years+ - NCT06289270Recruiting
Bladder cancer and urine bacteria study
This study looks at bacteria in urine and the bladder to understand if they play a role in causing bladder cancer. Researchers will compare samples from men with bladder cancer and healthy controls.
Cairo, Giza GovernorateAges 18 years+ - NCT06241846RecruitingPhase 2
Study of YL201 for advanced prostate cancer that has spread and stopped responding to hormone therapy
This trial tests a new drug, YL201, in men with advanced prostate cancer that has spread and is no longer controlled by standard hormone therapy. The goal is to see if YL201 can shrink tumors or slow the cancer's growth.
Hefei, AnhuiAges 18 years+ - NCT06278870RecruitingPhase 3
New drug combo vs standard for HER2+ advanced breast cancer
This trial compares two drug combinations for HER2-positive breast cancer that has spread. It tests a newer drug (Disitamab Vedotin + Pyrotinib) against a standard treatment (THP) as a first treatment option.
Guangzhou, GuangdongAges 18–75 - NCT06241781RecruitingPhase 2
Immune cells from your tumor for cervical cancer
This trial tests a new treatment using your own immune cells (called tumor-infiltrating lymphocytes) that are grown in a lab and given back to you. It is for people with cervical cancer that has come back or spread and hasn't been stopped by other treatments.
Beijing, Beijing MunicipalityAges 18–70 - NCT06329102Recruiting
Right colon cancer surgery and specimen quality study
This trial is studying how the type and method of surgery for right-sided colon cancer affects the quality of the removed tissue. It aims to improve surgical techniques for this type of cancer.
BergenAges 18–99 - NCT06305390RecruitingPhase 2
PSMA PET/MRI for prostate cancer diagnosis
This trial tests a new, all-in-one PET/MRI scan to see if it can better find aggressive prostate cancer in men who need a biopsy. It may help avoid unnecessary biopsies and give a clearer picture of your condition.
Milan, MilanoAges 18 years+ - NCT06184464Recruiting
Shrinking the prostate before radiation for prostate cancer
This trial tests how well the hormone drug leuprorelin acetate shrinks the prostate before radiation therapy for men with prostate cancer. The goal is to make radiation safer and more effective.
Terrassa, BarcelonaAges 18–95 - NCT06263361Recruiting
Making brain biopsies safer for lymphoma patients
This trial tests a new method to improve the safety and accuracy of brain biopsies in people with a type of lymphoma that starts in the brain or spinal cord. It may help reduce complications and get more reliable results.
Milan, MilanAges 18 years+ - NCT06256705Recruiting
Study of targeted radiation for neuroendocrine tumors
This study follows people with a type of digestive tract cancer called GEP-NET that has spread and is growing. It uses a special imaging scan to find tumors that absorb a radioactive drug, then treats them with targeted radiation therapy. The goal is to learn more about who benefits most from this treatment.
ClichyAges 18 years+ - NCT06223256RecruitingPhase 1
NBL-028 for advanced solid tumors with CLDN6
This trial tests a new drug called NBL-028 in people with advanced solid tumors that have a specific protein (CLDN6). It is for those who have already tried standard treatments. The goal is to see how safe and effective the drug is.
Shijiazhuang, HebeiAges 18 years+ - NCT06271057RecruitingPhase 2
Golcadomide after CAR T-cell for high-risk large B-cell lymphoma
This trial tests a new drug, golcadomide, given after CAR T-cell therapy to prevent relapse in people with aggressive large B-cell lymphoma who are at high risk. If you've had or are about to receive CAR T-cells, this study may help keep your lymphoma in remission.
CréteilAges 18 years+ - NCT06276686RecruitingEarly Phase 1
Exercise With Chemoradiotherapy for Locally Advanced Rectal Cancer
This study tests whether adding regular exercise during your standard chemoradiotherapy can help the treatment work better for people with locally advanced rectal cancer. It is designed for patients who have already been offered this type of therapy before surgery.
Cottingham, East YorkshireAges 18 years+ - NCT06327685RecruitingPhase 1
Avapritinib and Decitabine for SM-AHN
This trial tests a combination of two drugs, avapritinib and decitabine, for people with systemic mastocytosis plus another blood cancer (SM-AHN). The goal is to see if the combination works better than either drug alone.
Phoenix, ArizonaAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,587 recruiting oncology studies from the U.S. registry right now, out of 31,171 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.